ArticleNPJ breast cancer2025

Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines.

Ilenia Migliaccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.